Stan Renbarger
The service provided by Diatos was average. The customer support was helpful but not exceptional. I had some issues with the website functionality, but overall, it was an okay experience.
Ask AI about Diatos
AI-generated from reviews on this page. Verify anything important with the company directly.
Ming Chiu
I had a good experience with Diatos. The website is user-friendly, and their customer support was helpful. I would definitely use their services again.
Jeffery Preucil
Diatos provides a convenient platform to manage tasks efficiently. The website is user-friendly, and their customer support is highly responsive. I'm satisfied with their service!
Vijay Chaudhary
I recently tried a new service and I'm impressed. The platform is user-friendly and the support team resolved my queries quickly. Definitely recommend it!
Maggie Whitehurst
The service provided by Diatos was satisfactory. It fulfilled my requirements, and I had a smooth experience overall. The customer support team was responsive. Good job!
Loan Ho
😃 I had a wonderful experience with Diatos. The platform is intuitive and the customer support team is fantastic. They resolved my queries promptly. Keep up the good work!
Pongsaton Keng
👍 I had an excellent experience using Diatos' services. The website is intuitive and easy to navigate. The customer support was friendly and resolved my concerns promptly. Thumbs up!
Adrian Walker
The service provided by them was satisfactory. It met my expectations, and I had no major issues. However, there is room for improvement in terms of website performance.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Diatos
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA.
Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).
- Website
- diatos.com
- contact@diatos.com